Regulation of Energy Balance

OR19-1

OR19-2

FGF21 Therapy Improves Cognitive Function Impaired By Obese-Insulin Resistant Condition Via Restoring Synaptic Plasticity and Brain Mitochondrial Function
Piangkwan Sa-nguanmoo, Pongpan Tanajak, Sasiwan Kerdphoo, Pattarapong Satjaritanun, Xiaojie Wang, Guang Liang, Xiaokun Li, Chao Jiang, Wasana Pratchayasakul, Nipon Chattipakorn and Siriporn C Chattipakorn

OR19-3

Intranasal Oxytocin Reduces the Expression of Impulsive Behavior in Overweight and Obese Men
Franziska Plessow, Dean A. Marengi Jr., Sylvia K. Perry and Elizabeth A. Lawson

OR19-4

Measurement of Immunofunctional Leptin to Detect Patients with Functional Leptin Deficiency
Martin Wabitsch, Lutz Pridzun, Michael B Ranke, Bertram Flehmig, Pamela Fischer-Posovszky, Anja Moss, Michael Schaab, Julia von Schnurbein and Jürgen Kratzsch

OR19-5

Dysfunctional Subcutaneous Adipose Tissue Characterized By Reduced Dicer and Brown Adipose Tissue Gene Expression in HIV-Infected Patients
Martin Torriani, Suman Srinivasa, Kathleen V Fitch, Thomas Thomou, Kimberly Wong, Eva Petrow, C. Ronald Kahn, Aaron Martin Cypess and Steven K. Grinspoon

OR19-6

Postprandial Plasma Levels of FGF19 Are Increased in Patients with Post-Bariatric Hypoglycemia
Christopher M. Mulla, Allison B. Goldfine, Jonathan M. Dreyfuss, Hui Pan and Mary Elizabeth Patti